|Advances in Medical Diagnostics|
A one-day course, delivered in collaboration with the University of Strathclyde & Cranfield University, which will review new developments in nanotechnology as applied to IVDs, including lab-on-a-chip devices, DNA chips, nanoarrays, etc.
Who should attend?
The course will be invaluable to
- medical professionals
- industry researchers
- and others interested in gaining knowledge of this rapidly developing area of nanomedicine
The course will cover, amongst other topics, how
- lab-on-a-chip technologies
- gene and protein chips
- biosensor technologies
- scanning probe microscopy
- in-vivo nano-imaging
are being applied to provide newopportunities for the early diagnosis and treatment of cancer, cardiovascular and central nervous system disease, diabetes and other diseases as well as contributing towards lowering costs in increasingly pressured healthcare systems.
It has become clear that nanotechnology offers considerable scope for resolving issues in the diagnosis of a wide range of diseased states. This emerging technology may be of considerable importance in those conditions which pose a significant and defined challenge to society. In particular, nanotechnological solutions have the potential to impact significantly on the diagnosis and treatment of:
- Central nervous system (CNS) conditions
- Cardiovascular disease
The drive for sensitive focused diagnostic tools for these common, though challenging conditions is assuming more significance with the emergence of an aging population with greater expectations in terms of quality of life and general health.
For further information please telephone Gemma McCulloch at the Institute of Nanotechnology: +44 (0)1786 458075,
or email: email@example.com